MiR-219-5p Inhibits the Growth and Metastasis of Malignant Melanoma by Targeting BCL-2

被引:30
|
作者
Long, Jianwen [1 ,2 ,3 ]
Menggen, Qiqige [4 ]
Wuren, Qimige [4 ]
Shi, Quan [2 ,3 ]
Pi, Xianming [2 ,3 ]
机构
[1] Hubei Univ Chinese Med, Sch Clin Med 1, Dept Dermatol, Wuhan, Hubei, Peoples R China
[2] Hubei Prov Hosp Tradit Chinese Med, Dept Dermatol, Wuhan, Peoples R China
[3] Hubei Prov Acad Tradit Chinese Med, Dept Dermatol, Wuhan, Hubei, Peoples R China
[4] Mongolian Med Hosp, Dept Dermatol, Bortala Mongol Autonomou, Peoples R China
关键词
CANCER; IMMUNOTHERAPY; EXPRESSION; MICRORNAS; INVASION; ROLES; CELLS;
D O I
10.1155/2017/9032502
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Malignant melanoma is a very dangerous tumor which is resistant to conventional therapy. MicroRNA exerts a vital function in promoting or inhibiting tumor development. The research has investigated the expression and function of miR-219-5p inmelanoma. As a result, miR-219-5p expression was distinctly reduced inmelanoma tissues and cell lines and was negatively correlated with Bcl-2 protein level in melanoma. Patients with low miR-219-5p level represented obviously a low overall survival in comparison with patients with high miR-219-5p level. The upregulation of miR-219-5p inhibited melanoma growth and metastasis and strengthened melanoma cells chemosensitivity by targeting Bcl-2. Therefore, the modulation of miR-219-5p expression may be a novel treatment strategy in melanoma.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2
    Feng Xing
    Zhijiao Song
    Yuanying He
    [J]. Biological Research, 51
  • [2] MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2
    Huang, W-T
    Zhang, H.
    Jin, Z.
    Li, K.
    Hu, C.
    Li, M-L
    Situ, J.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (09) : 4710 - 4718
  • [3] miR-219-5p Inhibits Receptor Tyrosine Kinase Pathway by Targeting EGFR in Glioblastoma
    Rao, Soumya Alige Mahabala
    Arimappamagan, Arivazhagan
    Pandey, Paritosh
    Santosh, Vani
    Hegde, Alangar Sathyaranjandas
    Chandramouli, Bangalore Ashwathnarayanara
    Somasundaram, Kumaravel
    [J]. PLOS ONE, 2013, 8 (05):
  • [4] MiR-219-5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican-3
    Huang, Na
    Lin, Jing
    Ruan, Jian
    Su, Ning
    Qing, Ruzhai
    Liu, Feiye
    He, Benfu
    Lv, Chengwei
    Zheng, Dayong
    Luo, Rongcheng
    [J]. FEBS LETTERS, 2012, 586 (06) : 884 - 891
  • [5] miR-219-5p Modulates Cell Growth of Papillary Thyroid Carcinoma by Targeting Estrogen Receptor α
    Huang, Chen
    Cai, Zhaogeng
    Huang, Mingzhu
    Mao, Chaoming
    Zhang, Qifa
    Lin, Yi
    Zhang, Xiaomei
    Tang, Bi
    Chen, Yuqing
    Wang, Xiaojing
    Qian, Zhongqing
    Ye, Lei
    Peng, Yongde
    Xu, Huanbai
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : E204 - E213
  • [6] MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2 (Publication with Expression of Concern. See vol. 43, 2023)
    Xing, Feng
    Song, Zhijiao
    He, Yuanying
    [J]. BIOLOGICAL RESEARCH, 2018, 51
  • [7] miR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2
    Zhang, Z. R.
    Yang, N.
    [J]. NEOPLASMA, 2020, 67 (04) : 813 - 824
  • [8] miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin
    Wang, Quhui
    Zhu, Lirong
    Jiang, Yasu
    Xu, Junfei
    Wang, Feiran
    He, Zhixian
    [J]. ONCOLOGY LETTERS, 2017, 13 (03) : 1319 - 1324
  • [9] miR-219-5p inhibits proliferation and clonogenicity in chordoma cells and is associated with tumor recurrence
    Wei, Wei
    Zhang, Qiuhang
    Wang, Zhenlin
    Yan, Bo
    Feng, Yanjun
    Li, Pu
    [J]. ONCOLOGY LETTERS, 2016, 12 (06) : 4568 - 4576
  • [10] miR-219 inhibits the growth and metastasis of TSCC cells by targeting PRKCI
    Song, Kai-Bin
    Liu, Wen-Juan
    Jia, Shen-Shan
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2014, 7 (09): : 2957 - 2965